Back to Authors

Thomrongsith, Lisa

A5078378317

Mayo Clinic

Kite, a Gilead company, Santa Monica, CA;

Citations 1

A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS3103-TPS3103

10.1200/jco.2018.36.15_suppl.tps3103